• Europlasma reported first-half 2026 revenue of €22.3 million, affected by lower production rates in its Industries segment.
• The Industries segment was the main drag on operating performance.
• The update addressed going-concern considerations and preferred options.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Europlasma SA published the original content used to generate this news brief on October 30, 2026, and is solely responsible for the information contained therein.